154 related articles for article (PubMed ID: 38153975)
1. Preserflo TM MicroShunt implantation combined with Ologen TM in primary and secondary glaucoma patients in a clinical setting.
Rojo-Arnao M; Martinez-de-la-Casa JM; Albis-Donado O; Yañez-Castro G; Maroto-Cejudo R; Téllez J; Menoyo-Calatayud R
Indian J Ophthalmol; 2024 Mar; 72(3):417-426. PubMed ID: 38153975
[TBL] [Abstract][Full Text] [Related]
2. PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma.
Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Bechrakis N; Kohlhaas M
J Curr Ophthalmol; 2022; 34(2):180-186. PubMed ID: 36147269
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation.
Vastardis I; Fili S; Perdikakis G; Kontopoulou K; Balidis M; Gatzioufas Z; Kohlhaas M
Eye Vis (Lond); 2021 Sep; 8(1):33. PubMed ID: 34479641
[TBL] [Abstract][Full Text] [Related]
5. Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study.
Bhayani R; Martínez de la Casa JM; Figus M; Klabe K; Rabiolo A; Mercieca K
Eye (Lond); 2023 Mar; 37(4):644-649. PubMed ID: 35277663
[TBL] [Abstract][Full Text] [Related]
6. XEN
Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
[TBL] [Abstract][Full Text] [Related]
7. Device-modified trabeculectomy for glaucoma.
Park J; Rittiphairoj T; Wang X; E JY; Bicket AK
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010472. PubMed ID: 36912740
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of the Preserflo
Majoulet A; Scemla B; Hamard P; Brasnu E; Hage A; Baudouin C; Labbé A
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498660
[No Abstract] [Full Text] [Related]
9. PreserFlo™ MicroShunt Versus Ab Externo Canaloplasty in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Retrospective Study.
Habbe KJ; Kohlhaas M; Fili S
Cureus; 2023 Feb; 15(2):e35185. PubMed ID: 36960244
[TBL] [Abstract][Full Text] [Related]
10. PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety.
Jamke M; Herber R; Haase MA; Jasper CS; Pillunat LE; Pillunat KR
Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2901-2915. PubMed ID: 37133501
[TBL] [Abstract][Full Text] [Related]
11. Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.
Sen M; Midha N; Sidhu T; Angmo D; Sihota R; Dada T
Ophthalmol Glaucoma; 2018; 1(2):88-98. PubMed ID: 32677614
[TBL] [Abstract][Full Text] [Related]
12. PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study.
Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Kohlhaas M
Cureus; 2022 Aug; 14(8):e28288. PubMed ID: 36158358
[TBL] [Abstract][Full Text] [Related]
13. PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety.
Pillunat KR; Herber R; Haase MA; Jamke M; Jasper CS; Pillunat LE
Acta Ophthalmol; 2022 May; 100(3):e779-e790. PubMed ID: 34331505
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.
Ibarz Barberá M; Martínez-Galdón F; Caballero-Magro E; Rodríguez-Piñero M; Tañá-Rivero P
J Glaucoma; 2022 Jul; 31(7):557-566. PubMed ID: 35583510
[TBL] [Abstract][Full Text] [Related]
15. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention.
Armstrong JJ; De Francesco T; Ma J; Schlenker MB; Ahmed IIK
Ophthalmol Glaucoma; 2023; 6(5):480-492. PubMed ID: 37044278
[TBL] [Abstract][Full Text] [Related]
16. One-Year Outcomes of Preserflo
Nobl M; Grün C; Kassumeh S; Priglinger S; Mackert MJ
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109334
[TBL] [Abstract][Full Text] [Related]
17. Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation.
Aghayeva FA; Chronopoulos P; Schuster AK; Pfeiffer N; Hoffmann EM
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3045-3053. PubMed ID: 33963917
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Short-term Outcomes of Aurolab Aqueous Drainage Implant with Ahmed Glaucoma Valve in Post-Penetrating Keratoplasty Glaucoma: A Retrospective Follow-up Study at a Tertiary Care Center.
Raj S; Jurangal A; Gupta G; Thattaruthody F; Seth NG; Pandav SS
Ophthalmol Glaucoma; 2019; 2(3):172-177. PubMed ID: 32672587
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive bleb surgery versus minimally invasive glaucoma surgery: a 12-month retrospective study.
Konopińska J; Gołaszewska K; Saeed E
Sci Rep; 2024 Jun; 14(1):12850. PubMed ID: 38834618
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom.
Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S
Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
